Scholars Central

Mini reviewPublished 28 Aug 2022

Insulin Resistance Care Effectiveness in Patients with Schizophrenia A Mixed-Methods Exploration

Authors: Nouf M Aloudah

Clinical Pharmacy Department, King Saud University, Riyadh, Saudi Arabia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The prevalence and incidence of Type 2 diabetes have increased dramatically over the last two decades. Saudi Arabia has an estimated two million adults with diabetes, ranking seventh in the world and second in the Middle East.The global prevalence of schizophrenia is percent, with 40 percent of cases remaining untreated [1-15].In Saudi Arabia,the lifetime prevalence of psychological disorders is 34.2 percent. 4 Furthermore, the prevalence of schizophrenia is unknown. There is a wealth of data indicating that patients with schizophrenia are at least twice as likely as the general population to develop Type 2 diabetes. 5,6 Furthermore, patients with schizophrenia have a higher risk of death, with a life expectancy 13-15 years lower than patients without schizophrenia. While the exact causes of Type 2 diabetes in patients with schizophrenia are unknown, research suggests that it is a combination of genetics, atypical antipsychotic treatment, the long duration of schizophrenia, an unhealthy lifestyle,and high triglycerides Several studies have looked into undiagnosed Type 2 diabetes in patients with severe mental illness.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Advance Innovations, Thoughts & Ideas
  • SubjectDiabetes & Endocrinology
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Nouf M Aloudah”